TW200505943A - Polypeptide - Google Patents

Polypeptide

Info

Publication number
TW200505943A
TW200505943A TW093108716A TW93108716A TW200505943A TW 200505943 A TW200505943 A TW 200505943A TW 093108716 A TW093108716 A TW 093108716A TW 93108716 A TW93108716 A TW 93108716A TW 200505943 A TW200505943 A TW 200505943A
Authority
TW
Taiwan
Prior art keywords
polypeptide
cell
acid sequence
amino acid
composition containing
Prior art date
Application number
TW093108716A
Other languages
English (en)
Other versions
TWI350292B (zh
Inventor
Toshiki Nishizawa
Original Assignee
Hayashibara Biochem Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Biochem Lab filed Critical Hayashibara Biochem Lab
Publication of TW200505943A publication Critical patent/TW200505943A/zh
Application granted granted Critical
Publication of TWI350292B publication Critical patent/TWI350292B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
TW093108716A 2003-03-31 2004-03-30 Polypeptide TW200505943A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003093243 2003-03-31

Publications (2)

Publication Number Publication Date
TW200505943A true TW200505943A (en) 2005-02-16
TWI350292B TWI350292B (zh) 2011-10-11

Family

ID=33127353

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093108716A TW200505943A (en) 2003-03-31 2004-03-30 Polypeptide

Country Status (9)

Country Link
US (3) US7384636B2 (zh)
EP (1) EP1614695A4 (zh)
JP (1) JP4724000B2 (zh)
KR (1) KR20060003865A (zh)
CN (1) CN100410276C (zh)
AU (1) AU2004226032B2 (zh)
CA (2) CA2734606A1 (zh)
TW (1) TW200505943A (zh)
WO (1) WO2004087767A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1992639A4 (en) * 2006-02-22 2009-08-26 Hayashibara Biochem Lab PEPTIDE VACCINE FOR INDUCING THE PRODUCTION OF AMYLOID ANTI-PEPTIDE ANTIBODIES
JP2011511796A (ja) * 2008-02-08 2011-04-14 コルゲート・パーモリブ・カンパニー デンタルワイプ
JP2013090574A (ja) * 2010-01-21 2013-05-16 Daiichi Sankyo Co Ltd ペプチドワクチン
RU2496867C2 (ru) 2011-04-25 2013-10-27 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО "АГРИ") Способ получения l-аминокислоты семейства глутамата с использованием коринеформной бактерии
KR101979800B1 (ko) * 2012-02-16 2019-05-20 삼성전자주식회사 위젯창을 이용한 데이터 전송 시스템 및 방법
JP6133431B2 (ja) 2012-11-24 2017-05-24 ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ．Ｈａｎｇｚｈｏｕ Ｄａｃ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． 親水性連結体及び薬物分子と細胞結合分子との共役反応における親水性連結体の使用
US10464955B2 (en) 2014-02-28 2019-11-05 Hangzhou Dac Biotech Co., Ltd. Charged linkers and their uses for conjugation
AU2019276162A1 (en) 2018-05-30 2021-01-07 Deutsches Krebsforschungszentrum Combined prophylactic and therapeutic vaccines
CN115403654A (zh) * 2022-05-19 2022-11-29 首都医科大学 熊果酰-Asp-Gly-Glu-Ala、其合成、活性和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817318A (en) * 1989-05-03 1998-10-06 Connaught Laboratories Limited Synthetic peptides for an HIV-1 vaccine
WO1994012141A1 (en) 1992-11-23 1994-06-09 Novamedix Limited Blood flow stimulator
CN1067721C (zh) * 1996-07-04 2001-06-27 中国科学院上海生物化学研究所 含前表面抗原1和2免疫决定簇的乙肝表面抗原
CN1086421C (zh) * 1997-10-14 2002-06-19 复旦大学 丙型肝炎病毒复合多价疫苗基因的合成与克隆
FR2776926B1 (fr) * 1998-04-07 2003-10-24 Inst Nat Sante Rech Med Lipopeptides inducteurs de cytotoxicite t lymphocytaire portant au moins un epitope t auxiliaire, et leurs utilisations pour la vaccination
JP2004517034A (ja) 2000-04-26 2004-06-10 バイオシンセマ インコーポレーテッド （神経）ペプチド結合ｒｇｄ（ａｒｇ−ｇｌｙ−ａｓｐ）
EP1461077A4 (en) * 2001-11-07 2006-01-25 Univ Duke POLYVALENT IMMUNOGEN

Also Published As

Publication number Publication date
CA2734606A1 (en) 2004-10-14
KR20060003865A (ko) 2006-01-11
WO2004087767A1 (ja) 2004-10-14
CA2521038C (en) 2011-10-04
JPWO2004087767A1 (ja) 2006-09-07
TWI350292B (zh) 2011-10-11
US7384636B2 (en) 2008-06-10
AU2004226032A1 (en) 2004-10-14
CN1768079A (zh) 2006-05-03
US20100280229A1 (en) 2010-11-04
US20090088390A1 (en) 2009-04-02
US20070020257A1 (en) 2007-01-25
EP1614695A1 (en) 2006-01-11
CA2521038A1 (en) 2004-10-14
JP4724000B2 (ja) 2011-07-13
CN100410276C (zh) 2008-08-13
EP1614695A4 (en) 2006-10-04
AU2004226032B2 (en) 2010-06-17

Similar Documents

Publication Publication Date Title
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
HK1088840A1 (en) Stable analogs of glp-1 glp-1
ATE404225T1 (de) Radiofluorierte peptide
IN2014CN02050A (zh)
MXPA04008077A (es) Anticuerpos ant-a° y su uso.
WO2007064917A3 (en) Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
NZ600731A (en) Oxyntomodulin peptide analogue
NO20063026L (no) Antistoffer
WO2002064057A3 (en) Use of cell penetrating peptides to generate antitumor immunity
RU2015103816A (ru) ПРОНИКАЮЩИЕ В КЛЕТКУ ПЕПТИДЫ, МИШЕНЬЮ КОТОРЫХ ЯВЛЯЕТСЯ eIF4E
TW200505943A (en) Polypeptide
NZ596501A (en) Casb7439 constructs
WO2007078633A3 (en) Bacteriocin inducer peptides
NZ591133A (en) Novel melanoma antigen peptide and uses thereof
AU2003239659A1 (en) Peptide epitopes common to antigens of the same multigene family
WO2005072766A3 (en) Peptides that bind to hsp90 proteins
WO2012015979A3 (en) Hmgb1-derived peptides enhance immune response to antigens
MX2010005816A (es) Epítopos de péptido de stat3.
WO2005092922A3 (de) Antigen des pm-2 antikörpers und dessen verwendung
NZ591827A (en) Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating immune reaction in a radiotherapy-induced immuno-compromised subject
ATE356140T1 (de) Gd3 mimetische peptide
PH12020552282A1 (en) Improvements in immunogenic conjugates
MY150639A (en) T cell adhesion molecule and antibody thereto
WO2006038101A3 (en) Novel cancer associated antibodies and antigens and their use in cancer diagnosis
WO2006123157A3 (en) Nematistatic protein

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees